Recent explosion at Zaporizhzhia nuclear power plant in Ukraine shows how pharma industry can pull together and take action in the face of adversity.
John L. McManus
Advertisement
John L. McManus is chief business officer of Partner Therapeutics
Articles by John L. McManus
Advertisement
Latest Updated Articles
Partnering to Respond to a Possible Nuclear ThreatPublished: May 25th 2022 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Relation Therapeutics Forms $1.7 Billion Multi-Program Collaboration with Novartis Advancing Therapeutics for Atopic Diseases
2
Pfizer Enters Exclusive Collaboration and License Agreement with Yao Pharma for Oral Small-Molecule GLP-1 Agonists
3
Eli Lilly’s Jaypirca Achieves Primary Endpoint in Head-to-Head Phase III Study Against Imbruvica Treating CLL/SLL
4
Is FDA Streamlining Regulations in the Biosimilar Space?
5
